14-Jan-2026
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
PRNewswire (Wed, 7-Jan 8:20 PM ET)
PRNewswire (Thu, 18-Dec 8:27 PM ET)
Kodiak Sciences' $160 Million Upsized Offering Marks Strategic Bet on Retina Therapeutics
Market Chameleon (Wed, 17-Dec 6:44 AM ET)
Kodiak Sciences Launches $160 Million Upsized Stock Offering—Key Facts Investors Need to Know
Market Chameleon (Wed, 17-Dec 4:23 AM ET)
Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock
PRNewswire (Tue, 16-Dec 10:55 PM ET)
Kodiak Sciences Announces Proposed Public Offering of Common Stock
PRNewswire (Mon, 15-Dec 4:01 PM ET)
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results
PRNewswire (Thu, 13-Nov 4:05 PM ET)
Kodiak Sciences to Present at Upcoming Investor Conferences
PRNewswire (Wed, 12-Nov 5:48 PM ET)
Kodiak’s KSI-101 Shows 90% Success Rate in Achieving Retinal Dryness by Week 20 in MESI Study
Market Chameleon (Wed, 5-Nov 4:12 AM ET)
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Kodiak Sciences trades on the NASDAQ stock market under the symbol KOD.
As of January 14, 2026, KOD stock price climbed to $28.67 with 792,142 million shares trading.
KOD has a beta of 2.81, meaning it tends to be more sensitive to market movements. KOD has a correlation of 0.15 to the broad based SPY ETF.
KOD has a market cap of $1.75 billion. This is considered a Small Cap stock.
In the last 3 years, KOD traded as high as $31.18 and as low as $1.37.
The top ETF exchange traded funds that KOD belongs to (by Net Assets): XBI, VTI, IWM, IBB, DWAS.
KOD has outperformed the market in the last year with a price return of +267.1% while the SPY ETF gained +20.0%. KOD has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +147.2% and +2.6%, respectively, while the SPY returned +4.4% and +0.5%, respectively.
KOD support price is $26.53 and resistance is $30.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KOD shares will trade within this expected range on the day.
